查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1880491

生物活性胜肽和营养保健品市场预测至2032年：按来源、功能、形式、应用和地区分類的全球分析

Bioactive Peptides & Nutraceuticals Market Forecasts to 2032 - Global Analysis By Source (Plant-derived Proteins, Animal-derived Proteins, Marine-derived Proteins and Microbial-derived Proteins), Function, Form, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球生物活性胜肽和营养保健品市场价值将达到 718.7 亿美元，到 2032 年将达到 1,391.7 亿美元，在预测期内复合年增长率为 9.9%。

生物活性胜肽由短链胺基酸组成，除了提供基本营养外，还能带来特定的健康益处。这些胜肽透过酵素加工、发酵和消化食物蛋白等方式产生，具有抗氧化、降血压、抗菌和增强免疫力等特性。含有这些胜肽的营养保健品被广泛用于维持健康和控製糖尿病、肥胖症和心臟病等慢性疾病。消费者对机能性食品和预防医学日益增长的兴趣正在推动市场成长。生物技术和胜肽萃取技术的创新拓展了这些胜肽在膳食补充剂、机能饮料和治疗产品中的应用范围，凸显了它们在现代医疗保健和健康领域的巨大潜力。

世界卫生组织（世卫组织）指出，心血管疾病在很大程度上可以透过改变生活方式来预防，例如健康饮食、体能活动和戒烟。世卫组织也强调，将每日盐摄取量限制在5克以下有助于降低血压，从而降低心臟病和中风的风险。

提高消费者的健康意识

生物活性胜肽和营养保健品市场的主要驱动力是消费者对健康和预防保健日益增长的兴趣。肥胖、糖尿病和心臟病等文明病的增加，促使人们寻求机能性食品和膳食补充剂。生物活性胜肽作为天然存在的蛋白质衍生物，因其安全性和有效性而优于人工合成替代品。这种转变促使製造商开发富含胜肽的产品，包括膳食补充剂、机能饮料和强化食品，以满足消费者日益增长的健康营养需求。消费者对更健康生活方式的偏好持续推动全球市场的扩张。

高昂的生产成本

生产成本不断上涨是生物活性胜肽和营养保健品市场面临的主要挑战。高效的萃取、纯化和配方製程需要对生物技术、专用酵素和精密设备进行大量投资。确保高品质的蛋白质原料并维持产品品质的稳定性进一步增加了成本。这些成本往往会推高零售价格，限制了产品在价格敏感型市场的进入。这些财务压力使得小规模生产商难以进入市场。因此，儘管消费者需求不断增长，但大规模生产高品质生物活性胜肽产品的经济负担正在阻碍市场成长。

胜肽类产品的创新

胜肽萃取、生物技术和製剂技术的进步为生物活性胜肽和营养保健品带来了巨大的成长潜力。现代方法能够生产出生物利用度更高、稳定性更强、且具有特异性健康功效的高品质胜肽。诸如包封、缓释性技术以及将其添加到各种食品中等技术，能够增强胜肽的功效并提升其对消费者的吸引力。这些创新使得开发针对特定健康需求的特效膳食补充剂、机能饮料和治疗性营养保健品成为可能。利用最尖端科技，企业能够实现产品差异化，拓展市场覆盖面，并进军新的地域市场。持续的研发投入将确保胜肽类产品在功能性营养和预防保健领域中保持领先地位。

激烈的竞争与市场饱和

生物活性胜肽和营养保健品市场面临日益激烈的竞争和市场饱和的威胁。众多全球及区域性生产商纷纷推出胜肽类强化产品，导致价格压力增大，利润空间萎缩。市场竞争激烈，产品差异化难度加大，消费者忠诚度下降。新参与企业必须投入大量资源用于行销、创新和研发，才能有效参与竞争。市场饱和，尤其是在成熟市场，会减缓成长速度，限制商机。在激烈的竞争中，企业被迫将目光投向新兴市场和细分领域，以维持市场地位并确保可持续盈利。

新冠疫情的感染疾病：

新冠疫情危机对生物活性胜肽和营养保健品市场产生了重大影响。日益增强的健康意识和对增强免疫力的需求，推动了富含胜肽的膳食补充剂、机能性食品和饮料的消费量成长。具有抗氧化、抗发炎和增强免疫力功效的产品广受欢迎。儘管供应链中断和生产延误最初阻碍了供应，但疫情加速了线上销售和电子商务管道的发展，从而扩大了消费者覆盖范围。整体而言，这场健康危机凸显了预防性营养的重要性，在推动即时需求的同时，也增强了全球生物活性胜肽和营养保健品市场的长期成长潜力。

预计在预测期内，植物来源蛋白细分市场将占据最大的市场份额。

在永续性和植物性饮食需求不断增长的推动下，预计植物来源蛋白将在预测期内占据最大的市场份额。这些蛋白质来自大豆、豌豆、米和小麦，提供人体必需胺基酸，这些胺基酸可以转化为具有多种健康益处的生物活性胜肽。由于其具有抗氧化、增强免疫力和调节血压的特性，植物蛋白被广泛应用于膳食补充剂、机能饮料和强化食品中。消费者对环保、符合道德标准和洁净标示产品的日益关注，并持续推动植物来源蛋白的普及，使其成为全球膳食补充剂配方中的首选成分。

预计在预测期内，免疫调节胜肽细分市场将呈现最高的复合年增长率。

预计在预测期内，免疫调节胜肽领域将实现最高成长率，这主要得益于人们对预防保健和免疫健康的日益关注。这些胜肽能够增强免疫反应，帮助抵抗感染疾病、发炎和压力相关疾病。消费者对营养在免疫力中所起作用的认识不断提高，尤其是在新冠疫情爆发之后，这促使人们更多地采用富含胜肽的膳食补充剂和机能性食品。持续的研究、新型配方以及给药方式的创新进一步提升了这些产品的吸引力。全球健康意识的不断增强正在推动免疫调节胜肽被添加到膳食补充剂、饮料和机能性食品中，从而推动市场强劲成长。

占比最大的地区：

预计在预测期内，北美将保持最大的市场份额，这得益于其先进的医疗保健体系、消费者高度的健康意识以及对机能性食品和膳食补充剂的强烈偏好。文明病的日益增加以及对预防医学的重视，正在推动对免疫支持和健康促进产品的需求。主要生产商的存在、先进的研发能力和严格的监管标准巩固了主导地位。此外，高效的电子商务平台和完善的通路确保了消费者能够广泛获取肽类膳食补充剂。这些因素共同巩固了北美在全球生物活性胜肽和营养保健品市场的主导地位，使其成为市场收入和成长的最大区域贡献者。

年复合成长率最高的地区：

在预测期内，亚太地区预计将实现最高的复合年增长率，这主要得益于消费者意识的提高、都市化的加快以及可支配收入的增加。预防医学、机能性食品和免疫支持产品在註重健康的人群中越来越受欢迎。不断拓展的数位化销售管道、日益增强的健身意识以及大规模的人口基数正在推动对肽类膳食补充剂的需求。此外，政府的支持、研发投入的增加以及国内外企业的参与也促进了市场的扩张。这些因素共同作用，使亚太地区成为生物活性胜肽和营养保健品市场成长速度最快、成长率最高的地区。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，对主要国家的市场规模和复合年增长率进行估算和预测（註：可行性需确认）。
  • 竞争基准化分析
    • 根据主要企业的产品系列、地理覆盖范围和策略联盟基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 原始研究资料
    • 次级研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物活性胜肽和营养保健品市场（按成分划分）

  • 介绍
  • 植物来源蛋白质
  • 动物源性蛋白质
  • 海洋来源蛋白质
  • 微生物蛋白

6. 全球生物活性胜肽和营养保健品市场（依功能划分）

  • 介绍
  • 抗氧化胜肽
  • 抗菌胜肽
  • 抗高血压胜肽
  • 免疫调节胜肽
  • 靶向发炎的胜肽
  • 神经支持胜肽

7. 全球生物活性胜肽和营养保健品市场（按形式划分）

  • 介绍
  • 粉末
  • 液体
  • 胶囊/片剂

8. 全球生物活性胜肽和营养保健品市场（按应用划分）

  • 介绍
  • 製药
  • 营养补充品
  • 机能性食品和饮料
  • 化妆品和个人护理
  • 农业和饲料

9. 全球生物活性胜肽和营养保健品市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与併购
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章 企业概况

  • Archer Daniels Midland Company
  • Seagarden AS
  • Phermpep Co. Ltd.
  • Arlak Biotech Pvt. Ltd.
  • Naturade
  • Royal DSM
  • MYOS RENS Technology Inc.
  • Valio Oy
  • Amway
  • BASF
  • Nestle
  • Beneo
  • Nuritas
  • HELIX BIOMEDIX
  • FrieslandCampina Domo
Product Code: SMRC32526

According to Stratistics MRC, the Global Bioactive Peptides & Nutraceuticals Market is accounted for $71.87 billion in 2025 and is expected to reach $139.17 billion by 2032 growing at a CAGR of 9.9% during the forecast period. Bioactive peptides consist of short amino acid chains that provide targeted health benefits beyond basic nutrition. Produced from food proteins via enzymatic processes, fermentation, or digestion, these peptides exhibit antioxidant, antihypertensive, antimicrobial, and immune-boosting properties. Nutraceuticals, incorporating these peptides, are widely used to support health and manage chronic conditions like diabetes, obesity, and heart disease. Increasing consumer interest in functional foods and preventive health is fueling market growth. Innovations in biotechnology and peptide extraction techniques are broadening their use in supplements, functional drinks, and therapeutic products, highlighting their potential in modern healthcare and wellness applications.

According to the World Health Organization (WHO), cardiovascular diseases are largely preventable through lifestyle changes such as healthy diet, physical activity, and avoiding tobacco. WHO emphasizes that reducing salt intake to less than 5 grams per day helps lower blood pressure and reduces the risk of heart disease and stroke.

Market Dynamics:

Driver:

Rising health awareness among consumers

The bioactive peptides and nutraceuticals market is significantly propelled by heightened consumer focus on health and preventive care. Increasing incidences of lifestyle-related conditions like obesity, diabetes, and heart disease are pushing individuals toward functional foods and dietary supplements. Natural, protein-derived solutions such as bioactive peptides are preferred over artificial alternatives due to perceived safety and efficacy. This shift has encouraged manufacturers to develop peptide-fortified products, including supplements, functional drinks, and fortified foods, meeting the growing demand for wellness-focused nutrition. Consumer inclination toward healthier lifestyles continues to drive market expansion worldwide.

Restraint:

High production costs

Elevated production costs present a key challenge to the bioactive peptides and nutraceuticals market. Efficient extraction, purification, and formulation processes involve significant investment in biotechnology, specialized enzymes, and advanced equipment. Securing premium protein sources and maintaining consistent product quality further raise expenses. These costs often result in higher retail prices, restricting accessibility in cost-sensitive markets. Smaller manufacturers may face difficulties entering the sector due to these financial demands. As a result, despite increasing consumer demand, the market's growth is hindered by the economic burden of producing high-quality bioactive peptide products on a large scale.

Opportunity:

Technological innovation in peptide-based products

Technological progress in peptide extraction, biotechnology, and formulation offers significant growth potential for bioactive peptides and nutraceuticals. Modern methods produce high-quality peptides with improved bioavailability, stability, and health-specific benefits. Techniques like encapsulation, controlled release, and incorporation into diverse food products enhance effectiveness and consumer appeal. These innovations allow the creation of specialized supplements, functional drinks, and therapeutic nutraceuticals targeting particular health needs. By utilizing cutting-edge technologies, companies can differentiate products, expand market reach, and enter new regions. Ongoing research and development ensure peptide-based products remain leading solutions in functional nutrition and preventive healthcare.

Threat:

Intense competition and market saturation

The market for bioactive peptides and nutraceuticals is threatened by heightened competition and oversaturation. Many global and regional manufacturers are launching peptide-enriched products, resulting in price pressure and shrinking profit margins. A crowded marketplace can make it difficult to differentiate offerings, potentially reducing consumer loyalty. New players must allocate substantial resources to marketing, innovation, and research to compete effectively. Market saturation, especially in mature regions, may slow growth and limit revenue opportunities. Companies are compelled to focus on emerging markets or specialized niches to maintain their market position and ensure sustained profitability amid intense competition.

Covid-19 Impact:

The COVID-19 crisis had a major impact on the bioactive peptides and nutraceuticals market. Growing health awareness and the need to enhance immunity led to increased consumption of peptide-fortified supplements, functional foods, and beverages. Products offering antioxidant, anti-inflammatory, and immune-supporting benefits gained significant popularity. While supply chain interruptions and production delays initially hindered availability, the pandemic accelerated online sales and e-commerce channels, enabling broader consumer reach. Overall, the health crisis highlighted the value of preventive nutrition, resulting in immediate demand growth and reinforcing long-term expansion opportunities for the bioactive peptides and nutraceuticals market worldwide.

The plant-derived proteins segment is expected to be the largest during the forecast period

The plant-derived proteins segment is expected to account for the largest market share during the forecast period, driven by sustainability and the rising demand for plant-focused diets. Sourced from soy, peas, rice, and wheat, these proteins provide essential amino acids that can be converted into bioactive peptides offering various health benefits. They are extensively used in dietary supplements, functional beverages, and fortified foods due to their antioxidant, immune-enhancing, and blood pressure-regulating properties. Growing consumer interest in environmentally friendly, ethical, and clean-label products continues to boost the adoption of plant-derived proteins, making them the preferred choice for nutraceutical formulations worldwide.

The immune-regulating peptides segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the immune-regulating peptides segment is predicted to witness the highest growth rate due to growing attention on preventive healthcare and immune wellness. These peptides strengthen immune responses and assist the body in combating infections, inflammation, and stress-related conditions. Heightened consumer awareness of nutrition's role in immunity, particularly after the COVID-19 pandemic, has increased adoption of peptide-fortified supplements and functional foods. Ongoing research, novel formulations, and innovations in delivery methods further enhance their appeal. Rising health consciousness globally is driving the incorporation of immune-regulating peptides in dietary supplements, beverages, and functional foods, fueling strong market expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by advanced healthcare systems, high consumer health awareness, and strong preference for functional foods and supplements. The rising prevalence of lifestyle related disorders and emphasis on preventive care fuel demand for immune-supporting and wellness-focused products. The presence of key manufacturers, sophisticated research capabilities, and stringent regulatory standards enhances market leadership. Furthermore, effective e-commerce platforms and well-established distribution channels ensure broad consumer access to peptide-based nutraceuticals. These factors collectively reinforce North America's dominant position in the global bioactive peptides and nutraceuticals market, making it the largest regional contributor to market revenue and growth.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rising consumer awareness, urbanization, and increasing disposable income. Preventive healthcare, functional foods, and immunity-supporting products are gaining popularity among health-conscious populations. Expanding digital sales channels, heightened fitness awareness, and a large demographic base are driving demand for peptide-based nutraceuticals. Furthermore, government support, enhanced research and development, and the presence of both local and international companies are boosting market expansion. These factors collectively position Asia Pacific as the region with the highest growth rate, making it the fastest-growing market for bioactive peptides and nutraceutical products.

Key players in the market

Some of the key players in Bioactive Peptides & Nutraceuticals Market include Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Valio Oy, Amway, BASF, Nestle, Beneo, Nuritas, HELIX BIOMEDIX and FrieslandCampina Domo.

Key Developments:

In November 2025, ADM marked the start of operations for a new carbon capture and storage project at its Columbus, Nebraska Corn Processing Complex, making the complex the largest bioethanol carbon capture facility in the world. The project leverages Tallgrass's Trailblazer pipeline to transport captured carbon dioxide (CO2) from ADM's ethanol plant in Columbus to Tallgrass' Eastern Wyoming Sequestration Hub for safe, permanent storage deep underground.

In October 2025, Amway has announced plans to invest Rs 100 crore in India over the next three to five years to enhance its distribution network and expand its physical retail presence. The investment will focus on empowering its direct-selling partners and strengthening supply chain capabilities.

In June 2025, BASF has opened its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.

Sources Covered:

  • Plant-derived Proteins
  • Animal-derived Proteins
  • Marine-derived Proteins
  • Microbial-derived Proteins

Functions Covered:

  • Antioxidant Peptides
  • Antimicrobial Peptides
  • Antihypertensive Peptides
  • Immune-regulating Peptides
  • Inflammation-targeting Peptides
  • Neuro-support Peptides

Forms Covered:

  • Powder
  • Liquid
  • Capsules/Tablets

Applications Covered:

  • Pharmaceuticals
  • Nutraceuticals
  • Functional Foods & Beverages
  • Cosmetics & Personal Care
  • Agriculture & Feed

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioactive Peptides & Nutraceuticals Market, By Source

  • 5.1 Introduction
  • 5.2 Plant-derived Proteins
  • 5.3 Animal-derived Proteins
  • 5.4 Marine-derived Proteins
  • 5.5 Microbial-derived Proteins

6 Global Bioactive Peptides & Nutraceuticals Market, By Function

  • 6.1 Introduction
  • 6.2 Antioxidant Peptides
  • 6.3 Antimicrobial Peptides
  • 6.4 Antihypertensive Peptides
  • 6.5 Immune-regulating Peptides
  • 6.6 Inflammation-targeting Peptides
  • 6.7 Neuro-support Peptides

7 Global Bioactive Peptides & Nutraceuticals Market, By Form

  • 7.1 Introduction
  • 7.2 Powder
  • 7.3 Liquid
  • 7.4 Capsules/Tablets

8 Global Bioactive Peptides & Nutraceuticals Market, By Application

  • 8.1 Introduction
  • 8.2 Pharmaceuticals
  • 8.3 Nutraceuticals
  • 8.4 Functional Foods & Beverages
  • 8.5 Cosmetics & Personal Care
  • 8.6 Agriculture & Feed

9 Global Bioactive Peptides & Nutraceuticals Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Archer Daniels Midland Company
  • 11.2 Seagarden AS
  • 11.3 Phermpep Co. Ltd.
  • 11.4 Arlak Biotech Pvt. Ltd.
  • 11.5 Naturade
  • 11.6 Royal DSM
  • 11.7 MYOS RENS Technology Inc.
  • 11.8 Valio Oy
  • 11.9 Amway
  • 11.10 BASF
  • 11.11 Nestle
  • 11.12 Beneo
  • 11.13 Nuritas
  • 11.14 HELIX BIOMEDIX
  • 11.15 FrieslandCampina Domo

List of Tables

  • Table 1 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Source (2024-2032) ($MN)
  • Table 3 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Plant-derived Proteins (2024-2032) ($MN)
  • Table 4 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Animal-derived Proteins (2024-2032) ($MN)
  • Table 5 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Marine-derived Proteins (2024-2032) ($MN)
  • Table 6 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Microbial-derived Proteins (2024-2032) ($MN)
  • Table 7 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Function (2024-2032) ($MN)
  • Table 8 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Antioxidant Peptides (2024-2032) ($MN)
  • Table 9 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Antimicrobial Peptides (2024-2032) ($MN)
  • Table 10 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Antihypertensive Peptides (2024-2032) ($MN)
  • Table 11 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Immune-regulating Peptides (2024-2032) ($MN)
  • Table 12 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Inflammation-targeting Peptides (2024-2032) ($MN)
  • Table 13 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Neuro-support Peptides (2024-2032) ($MN)
  • Table 14 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Form (2024-2032) ($MN)
  • Table 15 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Powder (2024-2032) ($MN)
  • Table 16 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 17 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Capsules/Tablets (2024-2032) ($MN)
  • Table 18 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Pharmaceuticals (2024-2032) ($MN)
  • Table 20 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Nutraceuticals (2024-2032) ($MN)
  • Table 21 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Functional Foods & Beverages (2024-2032) ($MN)
  • Table 22 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Cosmetics & Personal Care (2024-2032) ($MN)
  • Table 23 Global Bioactive Peptides & Nutraceuticals Market Outlook, By Agriculture & Feed (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.